IFF Q1 2026 net income $169 million vs prior-year loss; reported sales down 4%
IFF reported first quarter 2026 net sales of $2.74 billion, down 4% from the prior year, while reported EPS was $0.66 compared with a loss of $3.98 a year earlier, which included a $1.153 billion goodwill impairment. The company reaffirmed its full-year 2026 guidance and said it is running a sale process for its Food Ingredients business, which may affect shareholders depending on the outcome.
Key points
- Reported net sales were $2.74 billion, down 4% versus $2.84 billion in the prior-year quarter; comparable currency neutral sales rose 3%.
- Reported EPS was $0.66 versus a loss of $3.98 per share a year earlier; adjusted EPS excluding amortization was $1.25 versus $1.20.
- Full-year 2026 guidance reaffirmed: sales of $10.5 billion to $10.8 billion and adjusted operating EBITDA of $2.05 billion to $2.15 billion.
- Soy Crush, Concentrates and Lecithin divestiture closed March 2, 2026; a disciplined sale process for Food Ingredients is ongoing.
The filing
Written by AI on Nov 8, 2026, 12:42 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on May 05, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.